Characterization of cytochrome P450 (CYP3A12) induction by rifampicin in dog liver

References

• BACKMAN, J. T., OLKKOLA, K. T. AND NEUVONEN, P. J., 1996, Rifampin drastically reduces plasma concentrations and effects of oral midazolum. Clinical Pharmacology and Therapeutics, 59, 7–13.
   PubMed Web of Science ®Google Scholar
• BORIN, M. T., CHAMBERS, J. H., CARL, B. J., GAGNox, S. AND FREIMUTH, W. W., 1997, Pharmaco-kinetic study of the interaction between rifampin and delavirdine mesylate. Clinical Pharmacology and Therapeutics, 61, 544–553.
   PubMed Web of Science ®Google Scholar
• CIACCIO, P. J. AND HALPERT, J. R., 1989, Characterization of a phenobarbital-inducible dog liver cytochrome P450 structurally related to rat and human enzymes of the P450IIIA (steroid-inducible) gene family. Archives of Biochemistry and Biophysics, 271, 284–299.
   PubMed Web of Science ®Google Scholar
• COMBALBERT, J., FABRE, I., FABRE, G., DALET I., DERANCOURT, J., CANO, J. P. AND MAUREL, P., 1989, Metabolism of cyclosporin A IV. Purification and identification of the rifampicin-inducible human liver cytochrome P-450 (cyclosporin A oxidase) as a product of P450IIIA gene family. Drug Metabolism and Disposition, 17, 197–207.
   Google Scholar
• DAUJAT, M., PICHARD, L., FABRE, I., PINEAU, T., FABRE, G., BONFILS, C. AND MAUREL, P., 1991, Induction protocols for cytochrome P450IIIA in vivo and in primary cultures of animal and human hepatocytes. Methods in Enzymology, 206, 345–353.
   PubMed Web of Science ®Google Scholar
• DUIGNAN, D. B., SIPES, I. G., CIACCIO, P. J. AND HALPERT, J. R., 1988, The metabolism of xenobiotics and endogenous compounds by the constitutive dog liver cytochrome P450 PBD-2. Archives of Biochemistry and Biophysics, 267, 294–304.
   PubMed Web of Science ®Google Scholar
• EGUCHI, K., NISHIBE, Y., BABA, T. AND OHNO, K., 1996, Quantitation of cytochrome P450 enzymes (CYP1A1/2,2B11,2C21 and 3Al2) in dog liver microsomes by enzyme-linked immunosorbent assay. Xenobiotica, 26, 755–764.
   PubMed Web of Science ®Google Scholar
• IMAOKA, S., TERANO, Y. AND FUNAE, Y., 1989, Expression of four phenobarbital-inducible cytochrome P-450s in liver, kidney, and lung of rats. Journal of Biochemistry, 105, 939–945.
   PubMed Web of Science ®Google Scholar
• JAYYOSI, Z., MUC, M., ERICK, J., THOMAS, P. E. AND KELLEY, M., 1996, Catalytic and immunochemical characterization of cytochrome P450 isozyme induction in dog liver. Fundamental and Applied Toxicology, 31, 95–102.
   PubMedGoogle Scholar
• KAMINSKY, L. S., FASCO, M. J. AND GUENGERICH, J. V., 1981, Production and application of antibodies to rat liver cytochrome P-450. Methods in Enzymology, 74, 262–272.
   PubMedGoogle Scholar
• KATO, R. AND YAMAZOE, Y., 1992, Sex-specific cytochrome P450 as a cause of sex- and species-related differences in drug toxicity. Toxicology Letter, 64/65, 661–667.
   Google Scholar
• KOCAREK, T. A., SCHUETZ, E. G., STROM, S. C., FISHER, R. A. AND GUZELIAN, P. S., 1995, Comparative analysis of cytochrome P4503A induction in primary cultures of rat, rabbit, and human hepatocytes. Drug Metabolism and Disposition, 23, 415–421.
   PubMed Web of Science ®Google Scholar
• LI, A. P., KAMINSKI, D. L. AND RASMUSSEN, A., 1995, Substrates of human hepatic cytochrome P450 3A4. Toxicology, 104, 1–8.
   PubMed Web of Science ®Google Scholar
• LOWRY, O. H., ROSENBROUGH N. J., FARR, A. L. AND RANDELL, R. J., 1951, Protein measurement with folin phenol reagent. Journal of Biological Chemistry, 193, 265–275.
   Google Scholar
• MATSUBARA, T., Toucm, A. AND OGAWA, A., 1982, Heterogenous distribution of cytochrome P-450 monooxygenase system in rat liver lobes. Japanese Journal of Pharmacology, 32, 999–1011.
   PubMedGoogle Scholar
• MATSUBARA, T., OTSUBO, S. AND YOSHIHARA, E., 1983, Liver microsomal cytochrome P-450-dependent 0-dealkylation reaction in various animals. Japanese Journal of Pharmacology, 33, 1065–1075.
   PubMedGoogle Scholar
• MOREL, F., BEAUNE, P. H., RATANASAVANH, D., FILNOIS, J. P., YANG, C. S., GUENGERICH, F. P. AND GUILLOUZO, A., 1990, Expression of cytochrome P-450 enzymes in cultured human hepatocytes. European Journal of Biochemistry, 191, 437–444.
   PubMedGoogle Scholar
• NEDELCHEVA, V. AND GUT, I., 1994, P450 in the rat and man: methods of investigation, substrate specificities and relevance to cancer. Xenobiotka, 24, 1151–1175.
   PubMed Web of Science ®Google Scholar
• NELSON, D. R., KAMATAKI, T., WAXMAN, D. J., GUENGERICH, F. P., ESTABROOK, R. W., FEYEREISEN, R., GONZALEZ, F. J., COON, M. J., GUNSALUS I. C., GOTOH, O., OKUDA, K. AND NEBERT, D. W., 1993, The P450 superfamily : update on new sequence, gene mapping, accesion number, early trivial names of enzymes and nomenclature. DNA and Cell Biology, 12, 1–51.
   Google Scholar
• NISHIBE, Y. AND HIRATA, M., 1993, Effect of phenobarbital and other model inducers on cytochrome P450 isoenzymes in primary culture of dog hepatocytes. Xenobiotica, 23, 681–692.
   PubMed Web of Science ®Google Scholar
• NISHIBE Y. AND HIRATA, M., 1995a, Induction of cytochrome P450 3A (CYP3A) by E5110, a non-steroidal anti-inflammatory agent (NSAID), and typical CYP3A inducers in primary culture of dog hepatocytes. Biological Pharmaceutical Bulletin, 18, 1142–1144.
   PubMed Web of Science ®Google Scholar
• NISHIBE, Y. AND HIRATA, M., 1995b, Induction of cytochrome P-450 isozymes in cultured monkey hepatocytes. International Journal of Biochemistry and Cell Biology, 27, 279–285.
   PubMed Web of Science ®Google Scholar
• NIWA, T., KANEKO, H., NARITOMI, Y., TOGAWA, A., SHIRAGA, T., IWASAKI, K., TOZAWA, Z. AND HATA, T., 1995, Species and sex differences of testosterone and nifedipine oxidation in liver microsomes of rat, dog and monkey. Xenobiotica, 25, 1041–1049.
   PubMed Web of Science ®Google Scholar
• OHTA, K., MOTOYA, M., KOMORI, M., MIURA, T., KITADA, M., NAGAO, M. AND KAMATAKI, T., 1990, Interspecies homology of cytochrome P-450: Purification and toxicological significance of a high spin form of cytochrome P-450 (P-450-D2) from liver microsomes of polychlorinated buphenyl (PCB)-treated beagle dogs. Journal of Biophamaceutical Sciences, 1, 59–71.
   Google Scholar
• OMURA, T. AND SATO, R., 1964, The carbon monoxide-binding pigment of liver microsomes. Journal of Biological Chemistry, 239, 2370–2378.
   PubMed Web of Science ®Google Scholar
• PARKE, B. K. AND BRECKENRIDGE, A. M., 1981, Clinical implications of enzyme induction and enzyme inhibition. Clinical Pharmacokinetics, 6, 1–24.
   PubMed Web of Science ®Google Scholar
• PICHARD, L., FABRE, I., FABRE, G., DOMERGUE, J., SAINT, B., MOURAD, A. G. AND MAUREL, P., 1990, Cyclosporin A drug interactions. Screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary cultures of human hepatocytes and in liver microsomes. Drug Metabolism and Disposition, 18, 595–606.
   PubMed Web of Science ®Google Scholar
• SAKAMOTO, K., KIRITA, S., BABA, T., NAKAMURA, Y., YAMAZOE, Y., KATO, R., TAKANAKA, A. AND MATSUBARA, T., 1995, A new cytochrome P450 form belonging to the CYP2D in dog liver microsomes: purification, cDNA cloning, and enzyme characterization. Archives of Biochemistry and Biophysics, 319, 372–382.
   PubMed Web of Science ®Google Scholar
• SHARER, J. E., SHIPLEY, L. A., YANDENBRANDEN, M. R., BINKLEY, S. N. AND WRIGHTON, S. A., 1995, Comparisons of phase I and phase II in vitro hepatic enzyme activities of human, dog, rhesus monkey, and cynomolgus monkey. Drug Metabolism and Disposition, 23, 1231–1241.
   PubMed Web of Science ®Google Scholar
• SHIMADA, T., YAMAZAKI, H., MEVIURA, M., INUI, Y. AND GUENGERICH, F. P., 1994, Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drug, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucacians. Journal of Pharmacology and Experimental Therapeutics, 270, 414–423.
   PubMed Web of Science ®Google Scholar
• SHIMADA, T., MIMURA, M., INOUE, K., NAKAMURA, S., ODA, H., OHMORI, S. AND YAMAZAKI, H., 1997, Cytochrome P450-dependent drug oxidation activities in liver microsomes of various animal species including rats, guinea pig, dogs, monkeys, and humans. Archives of Toxicology, 71, 401–408.
   PubMed Web of Science ®Google Scholar
• SHIRAGA, T., IWASAKI, K., NOZAKI, K., TAMURA, T., YAMAZOE, Y., KATO, R. AND TAKANAKA, A., 1994, Isolation and characterization of four cytochrome P450 isozymes from untreated and phenobarbital-treated beagle dogs. Biological and Pharmaceutical Bulletin, 17, 22–28.
   PubMed Web of Science ®Google Scholar
• SUMNER, I. G. AND LODOLA, A., 1987, Total cytochrome P-450, but not the major phenobarbitone or 3-methylcholanthrene induced isoenzyme, is differentially induced in the lobes of the rat liver. Biochemical Pharmacology, 36, 391–393.
   PubMed Web of Science ®Google Scholar
• VENKATESAN, K., 1992, Pharmacokinetic drug interactions with rifampicin. Clinical Pharmacokinetks, 22, 47–65.
   PubMed Web of Science ®Google Scholar
• VILLIKKA, K., Kivisth, K. T., BACJMAN J. T., OLKKOLA, K. T. AND NEUVONEN, P. J., 1997, Triazolam is ineffective in patients taking rifampin. Clinical Pharmacology and Therapeutics, 61, 8–14.
   Google Scholar
• WATKINS, P. B., MURRAY, S. A., THOMAS, P. E. AND WRIGHTON, S. A., 1990, Distribution of cytochrome P-450, cytochrome b5, and NADPH-cytochrome P-450 reductase in an entire human liver. Biochemical Pharmacology, 39, 471–476.
   PubMed Web of Science ®Google Scholar